Figure 1.

Study flow diagram. Twenty-four renal transplant children fulfilling the inclusion criteria from 131 studied renal graft biopsy samples. The children were randomized to receive placebo (n=11) or eplerenone (n=13) for 24 months. Only one patient from the placebo group discontinued the study treatment.